Word: astrazeneca
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Judith Hsia, senior director for clinical development at AstraZeneca, which makes Crestor, says the trial was designed to measure the statin's effect on all end points together, not individual end points. "The people who had bypass surgery or stenting would not characterize that as a nonevent," says Hsia. "It's not death, but it's still substantial...
Levine spoke about lung disease on behalf of drug companies like AstraZeneca and GlaxoSmithKline for about 18 years but says he does not plan to take on any more speaking engagements until the implications of the policy become clearer...
...Phase II clinical trial with the experimental drug cediranib conducted several years ago showed that patients treated with the drug survived longer compared to historical controls. Researchers wanted to know why this occurred, said Tracy T. Batchelor, one of the authors of the study and a consultant to AstraZeneca Pharmaceuticals, which produces cediranib. “This was a bench to bedside and back to bench journey,” added Batchelor, referring to the return to the laboratory after the drug’s clinical trial. The researchers used rodent models with three different kinds of glioblastoma and placed...
...damning indictment was part of a 400-page, interim Commission report based on evidence collected during January raids at the headquarters to some of the world's biggest drug companies, including U.S. companies Pfizer and Johnson & Johnson, Britain's GlaxoSmithKline, Anglo-Swedish giant AstraZeneca, and Sanofi-Aventis of France. The other companies known to be raided were Wyeth, Merck, Bayer Schering Pharma and Roche, as well as generic firms Teva and Sandoz...
...According to the pharmaceutical market news service Pharmawire, around $114 billion worth of drugs will go off patent in 2008-12, including lucrative brands such as Eisai's Aricept, which treats Alzheimers, and Pfizer's Lipitor, which lowers cholesterol. Some analysts say patent expirations could lead AstraZeneca and GlaxoSmithKline to lose up to one third of their sales...